Dark Chocolate Coconut Bar is dark chocolate with white chocolate and coconut, 1.2 oz (33g), product wrapped in metal foil and then wrapped in paper box.
Dolcetta Artisan Sweets
undeclared soy lecithin and milk
95,083 total recalls in our database
Dolcetta Artisan Sweets
undeclared soy lecithin and milk
The SoyNut Butter Company
Potential contamination of product with E. coli O157.
Tomales Bay Foods
Firm was notified by their supplier that the product may be contaminated with Listeria monocytogenes.
An FDA inspection at the manufacturing facility found seven products that do not properly declare wheat as a sub-ingredient of soy sauce in the ingredient list. Wheat is listed in the Contains statement.
Dolcetta Artisan Sweets
undeclared soy lecithin
Dolcetta Artisan Sweets
undeclared soy lecithin
An FDA inspection at the manufacturing facility found seven products that do not properly declare wheat as a sub-ingredient of soy sauce in the ingredient list. Wheat is listed in the Contains statement.
Dolcetta Artisan Sweets
undeclared soy lecithin.
Qinhuangdao Zizhu Pharmaceutical
cGMP Deviations; lack of quality assurance.
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Presence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mg
Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.
Mckesson Medical Surgical
Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.
Qinhuangdao Zizhu Pharmaceutical
cGMP Deviations; lack of quality assurance.
Qinhuangdao Zizhu Pharmaceutical
cGMP Deviations; lack of quality assurance.
Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection
Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.
Qinhuangdao Zizhu Pharmaceutical
cGMP Deviations; lack of quality assurance.